Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions
C Dehlendorff, P Sparén, B Baldur-Felskov… - Vaccine, 2018 - Elsevier
Background Based on immunogenicity studies, a 2 dose HPV vaccination-schedule was
recently recommended for girls younger than 15 years. We aimed to investigate the …
recently recommended for girls younger than 15 years. We aimed to investigate the …
Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: a population‐based study
E Herweijer, K Sundström, A Ploner… - … journal of cancer, 2016 - Wiley Online Library
Human papillomavirus (HPV) types 16/18, included in HPV vaccines, contribute to the
majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia …
majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia …
Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: a Danish nationwide cohort study
F Verdoodt, C Dehlendorff… - Clinical Infectious Diseases, 2020 - academic.oup.com
Background A reduced, 2-dose schedule of human papillomavirus (HPV) vaccination has
been endorsed for preadolescent women on the basis of immunogenicity data from …
been endorsed for preadolescent women on the basis of immunogenicity data from …
Potential impact of nonavalent HPV vaccine in the prevention of high‐grade cervical lesions and cervical cancer in Portugal
A Pista, CF de Oliveira, C Lopes… - … of Gynecology & …, 2017 - Wiley Online Library
Objective To estimate the potential impact of the nonavalent HPV vaccine for high‐grade
cervical lesions and invasive cervical cancer (ICC) in Portugal. Methods The present …
cervical lesions and invasive cervical cancer (ICC) in Portugal. Methods The present …
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15 …
H Sharma, S Parekh, P Pujari, S Shewale… - The Lancet …, 2023 - thelancet.com
Background To meet global cervical cancer elimination efforts, a wider range of affordable
and accessible vaccines against human papillomavirus (HPV) are needed. We aimed to …
and accessible vaccines against human papillomavirus (HPV) are needed. We aimed to …
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
SE Powell, S Hariri, M Steinau, HM Bauer, NM Bennett… - Vaccine, 2012 - Elsevier
BACKGROUND: Vaccination against human papillomavirus (HPV) types 16 and 18 is
recommended for girls aged 11 or 12 years with catch-up vaccination through age 26 in the …
recommended for girls aged 11 or 12 years with catch-up vaccination through age 26 in the …
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States–2008–2012
S Hariri, NM Bennett, LM Niccolai, S Schafer, IU Park… - Vaccine, 2015 - Elsevier
Background Prevention of pre-invasive cervical lesions is an important benefit of HPV
vaccines, but demonstrating impact on these lesions is impeded by changes in cervical …
vaccines, but demonstrating impact on these lesions is impeded by changes in cervical …
A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries
SK Kjaer, M Nygård, J Dillner… - Clinical Infectious …, 2018 - academic.oup.com
Background The long-term effectiveness of the quadrivalent human papillomavirus (qHPV)
vaccine was assessed by monitoring the combined incidence of cervical intraepithelial …
vaccine was assessed by monitoring the combined incidence of cervical intraepithelial …
High‐grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study
LH Thamsborg, G Napolitano… - Acta Obstetricia et …, 2020 - Wiley Online Library
Introduction It is pertinent to evaluate the impact of vaccination against human
papillomavirus (HPV) in real life. The aim of the study was to evaluate the real‐life impact of …
papillomavirus (HPV) in real life. The aim of the study was to evaluate the real‐life impact of …
The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland
K Cuschieri, T Palmer, C Graham, R Cameron… - British Journal of …, 2023 - nature.com
Background Understanding the pattern and dominance of HPV types in high grade cervical
disease within increasingly vaccinated populations will help inform the development of …
disease within increasingly vaccinated populations will help inform the development of …